Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

AB Science SA (0Q77) Share Price & Analysis

0 Followers

0Q77 Stock Chart & Stats

€0.58€0.05(8.77%)
At close: 4:30 PM GMT
€0.5€0.6€0.7Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 10
Day’s Range
EUR 0.58 - EUR 0.60
52-Week Range
EUR 0.51 - EUR 1.58
Previous Close
EUR 0.54
Volume
N/A
Average Volume (3M)
3,639
Market Cap
EUR 51.55M
Enterprise Value
EUR 55.79M
Total Cash (Recent Filing)
EUR 8.98M
Total Debt (Recent Filing)
EUR 4.74M
Price to Earnings (P/E)
―
Beta
0.54
Next Earnings
Apr 23, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Mar 15, 2022
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Recent revenue growth shows that AB Science is expanding its reported business base despite remaining loss-making. If this trajectory continues, a larger revenue stream could improve operating leverage and provide a stronger foundation for funding clinical development over the next several quarters.

Debt Reduction

The sharp reduction in debt materially lowers scheduled financing pressure and interest-related exposure compared with prior years. Although the balance sheet remains fragile, reduced borrowing gives management more flexibility to direct available resources toward research, regulatory work, and business development.

Proprietary Drug Pipeline

AB Science owns a focused drug-development platform centered on masitinib, with investigations spanning oncology and inflammatory or immune-related diseases. Progress in more than one therapeutic area creates several potential routes to regulatory authorization, commercialization, or future partnering income.

Bears Say

Persistent Unprofitability

Persistent operating and net losses indicate that the business has not yet reached an economically self-sustaining stage. Continued losses can constrain internal investment capacity, reduce earnings quality, and leave future clinical and regulatory progress dependent on securing additional funding or monetization events.

Negative Shareholder Equity

Persistently negative equity is a durable solvency warning because liabilities exceed the recorded asset base and financial flexibility remains limited. This weak capital structure makes the company more sensitive to ongoing losses and may complicate its ability to fund development without further capital actions.

Renewed Cash Burn

The return to substantial operating and free-cash-flow burn demonstrates that cash generation remains volatile and generally weak. If this pattern persists, AB Science will need continuing funding or business monetization to sustain research and regulatory activities, increasing liquidity risk over the medium term.

AB Science SA News

0Q77 FAQ

What was AB Science SA’s price range in the past 12 months?
AB Science SA lowest share price was €0.51 and its highest was €1.58 in the past 12 months.
What is AB Science SA’s market cap?
AB Science SA’s market cap is €51.55M.
When is AB Science SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were AB Science SA’s earnings last quarter?
AB Science SA released its earnings results on Oct 09, 2026. The company reported -€0.13 earnings per share for the quarter, missing the consensus estimate of -€0.07 by -€0.06.
Is AB Science SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does AB Science SA pay dividends?
AB Science SA pays a dividend of €0.285 which represents an annual dividend yield of ―. See more information on AB Science SA dividends here
What is AB Science SA’s EPS estimate?
AB Science SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AB Science SA have?
AB Science SA has 96,530,785 shares outstanding.
What happened to AB Science SA’s price movement after its last earnings report?
AB Science SA reported an EPS of -€0.13 in its last earnings report, missing expectations of -€0.07. Following the earnings report the stock price went up 2.559%.
Which hedge fund is a major shareholder of AB Science SA?
Currently, no hedge funds are holding shares in GB:0Q77
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology